In several areas of investigation, the results of a bumper year in osteoporosis research are set to stoke rather than settle debate. From the origins of bone health to the use of established and experimental therapies, the new findings will be discussed into 2011 and beyond.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Small leucine rich proteoglycans, a novel link to osteoclastogenesis
Scientific Reports Open Access 03 October 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cooper, C., Sayer, A. & Dennison, E. M. The developmental environment: clinical perspectives on effects on the musculoskeletal system, in Developmental Origins of Health and Disease (eds Gluckman, P. & Hanson, M.) 392–405 (Cambridge University Press, Cambridge, 2006).
Wang, Q. et al. Familial resemblance and diversity in bone mass and strength in the population are established during the first year of postnatal life. J. Bone Miner. Res. 25, 1512–1520 (2010).
Baird, J. et al. Does birthweight predict bone mass in adulthood? A systematic review and meta-analysis. Osteoporos. Int. doi:10.1007/s001980101344-9.
Watson, J., Wise, L. & Green, J. Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005. Eur. J. Clin. Pharmacol. 63, 843–849 (2007).
Abrahamsen, B. Adverse effects of bisphosphonates. Calcif. Tissue Int. 86, 421–435 (2010).
Khosla, S. et al. Bisphosphonate associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J. Bone Miner. Res. 22, 1479–1491 (2007).
Shane, E. et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J. Bone Miner. Res. 25, 2267–2294 (2010).
Cardwell, C. R., Abnet, C. C., Cantwell, M. M. & Murray, L. J. Exposure to oral bisphosphonates and risk of esophageal cancer. JAMA 304, 657–663 (2010).
Green, J. et al. Oral bisphosphonates and risk of cancer of oesophagus, stomach and colorectum: case–control analysis within a UK primary care cohort. BMJ 341, c4444 (2010).
Padhi, D., Jang, G., Stouch, B., Fang, L. & Posvar, E. Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J. Bone Miner. Res. doi:10.1002/jbmr.173.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Dennison, E., Cooper, C. Building bones and (safely) preventing breaks. Nat Rev Rheumatol 7, 80–82 (2011). https://doi.org/10.1038/nrrheum.2010.227
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2010.227
This article is cited by
-
Small leucine rich proteoglycans, a novel link to osteoclastogenesis
Scientific Reports (2017)